Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

709425.pdf (582.42 KB)

Document type

Article

Version

Published version

Publication date

2019-06-13

Publication license

cc-by (c) Piperno Neumann, Sophie et al., 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/176454

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.3390/cancers11060817

Abstract

Uveal melanoma (UM) is the most frequent primary ocular cancer in adults, accounting for 5% of all melanomas. Despite effective treatments for the primary tumour, up to 50% of UM patients will develop metastasis, leading to a very poor prognosis and a median overall survival of 6 to 12 months, with no major improvements in the last 30 years. There is no standard oncological treatment available for metastatic UM patients, and BRAF/MEK and immune checkpoint inhibitors show disappointing results when compared to cutaneous melanoma (CM). Recent advances in biology, however, identified specific gene and chromosome alterations, potentially permitting an actively tailored surveillance strategy, and dedicated clinical studies. Being a rare cancer, UM patients have to overcome issues such as identifying referral centres, having access to information, and partnering with oncologists for specific management strategies and research priorities. Here, we describe how the EUropean Rare Adult solid CAacer Network (EURACAN) will help in addressing these challenges and accelerating international collaborations to enhance the development of innovative treatments in UM.

Subject

Melanoma, Iris (Ull)

Subject (English)

Melanoma, Iris (Eye)

Citation

Collections

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

PIPERNO-NEUMANN, Sophie, et al. Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer. Cancers. 2019. Vol. 11, num. 6. ISSN 2072-6694. [consulted: 12 of August of 2026]. Available at: https://hdl.handle.net/2445/176454

Export metadata

JSON - METS

Share record